Epigral Ltd

BSE
EPIGRAL •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Epigral Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
70.43% Gain from 52W Low
11.3
TTM PE Ratio
Below industry Median
31.2
Price to Book Ratio
Below industry Median
4.9
Dividend yield 1yr %
Below industry Median
0.3
TTM PEG Ratio
PEG TTM is negative
-0.7
RSI
RSI is mid-range
57
MFI
MFI is mid-range
52.1

Epigral Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Epigral Ltd shareholding Pattern

Promoter
71.6%
Foreign Institutions
1.5%
Domestic Institutions
0.2%
Public
26.8%
Promoter
71.5%
Foreign Institutions
1.4%
Public
27.1%
Promoter
71.4%
Foreign Institutions
1.2%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.4%
Foreign Institutions
1.1%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.4%
Foreign Institutions
1.2%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.3%
Foreign Institutions
1.2%
Public
27.4%

Epigral Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
1,450.30
10Day EMA
1,455.60
12Day EMA
1,454.50
20Day EMA
1,439.60
26Day EMA
1,425.30
50Day EMA
1,374.20
100Day EMA
1,292.10
200Day EMA
1,198.00
5Day SMA
1,442.10
10Day SMA
1,467.60
20Day SMA
1,449.70
30Day SMA
1,416.00
50Day SMA
1,350.40
100Day SMA
1,285.10
150Day SMA
1,192.70
200Day SMA
1,127.80
Delivery & Volume
Resistance & Support
1,445.25
Pivot
Resistance
First Resistance
1,503.95
Second Resistance
1,538.70
Third Resistance
1,597.40
Support
First Support
1,410.50
Second support
1,351.80
Third Support
1,317.05
Relative Strength Index
56.95
Money Flow Index
52.11
MACD
29.16
MACD Signal
40.65
Average True Range
59.52
Average Directional Index
19.71
Rate of Change (21)
4.27
Rate of Change (125)
45.01
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Balaji Amines Ltd.
7384.84
1965.05
2736.35
NOCIL Ltd.
4990.21
208
319
Sudarshan Chemical Industries Ltd.
6186.15
440
963.15
Privi Speciality Chemicals Ltd.
5938.31
975
1679
Rossari Biotech Ltd.
4523.66
657.8
895
Laxmi Organic Industries Ltd.
7064.69
220
320.7

Epigral Ltd Company background

Founded in: 2007
Managing director: Maulik Jayantibhai Patel
Meghmani Finechem Limited was incorporated in 2007 as a subsidiary of Meghmani organics ltd, under the provisions of Companies Act, 1956. The Company at present is primarily engaged in manufacturing and selling of Chlor Alkali its Derivatives. The Company is also engaged in Trading of Agrochemical products.The Honble National Company Law Tribunal (NCLT) Ahmedabad Bench vide its order dated 3 May 2021 (the Order), has approved the Scheme of Arrangement (the Scheme) to demerge the Agrochemicals and Pigments Division of Meghmani Organics Limited (MOL) alongwith its investment in Optionally Convertible Redeemable Preference Shares (OCRPS) of Meghmani Finechem Limited (MFL) and transferred to the Company as a going concern. The certified true copy of the Order issued by NCLT Ahmedabad Bench on 05th May, 2021 filed with The Ministry of Corporate Affairs (the MCA) Registrar of Companies (ROC) Gujarat, Dadra, Nagar and Haveli on 10th May, 2021. The Scheme is effective from 10th May, 2021. By this Meghmani Finechem Limited was demerged from Meghmani Organics in FY 202021 to empower the Company grow its ChlorAlkali business. The demerged Company is now being driven by the second generation of the promoter family that came on the Board of the Company in 2016. The Companys ChlorAlkali business was commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 202021. The Company is now among the leading players in Indias chlor alkali industry.The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive PowerPlant). The timely commissioning of the plants represented the faith of the management in the longterm potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The complement of these manufacturing capacities will broadbase the Companys manufacturing foundation, strengthen integration, moderate the cost structure and provide a platform for valueaddition. The payback from these investments is likely to be recovered in 45 years, validating the Companys commitment to profitable growth.During the year under review 202021, the Company announced the implementation of a manufacturing facility for Epichlorohydrin (ECH) and Chlorinated Polyvinyl Chloride (CPVC) which are expected to add attractively to the Companys volumes and profitability across the future. The ECH project will be the first time that the product will be manufactured in India. The 50,000 TPA facility will be based on glycerin feedstock that is obtained from 100% renewable resources, addressing the need for costeffectiveness and moderated carbon footprint. The project is likely to be commissioned during the first quarter of the next financial year. The CPVC Resin project of 30,000 TPA at a cost of H190 Cr is likely to be commissioned in the second quarter of FY 202223.
Read More

Epigral Ltd FAQs

The past 1-year return of Epigral Ltd [EPIGRAL] share was 52.77. The Epigral Ltd [EPIGRAL] share hit a 1-year low of Rs. 870 and a 1-year high of Rs. 1582.1.

The Mutual Fund Shareholding was 0.05% at the end of .

You can easily buy Epigral Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -